Section 845IAC2-1-9. Morphine equivalent doses above 60; revising of assessments and treatment plans

   When a patient's opioid dose reaches a morphine equivalent dose of more than sixty (60) milligrams per day, a face-to-face review of the treatment plan and patient evaluation must be scheduled, including consideration of referral to a specialist. If the podiatrist elects to continue providing opioid therapy at a morphine equivalent dose of more than sixty (60) milligrams per day, the podiatrist must develop a revised assessment and treatment plan for ongoing treatment. The revised assessment and treatment plan must be documented in the patient's chart, including an assessment of increased risk for adverse outcomes, including death, if the podiatrist elects to provide ongoing opioid treatment. (Board of Podiatric Medicine; 845 IAC 2-1-9; filed Jul 15, 2016, 10:27 a.m.: 20160810-IR-845150416FRA)

*